Form 4: Protagonist Therapeutics CFO Asif Ali Reports Stock Transactions
SEC Form 4
Asif Ali, CFO of Protagonist Therapeutics, reports exercising stock options and selling shares on March 12, 2025.
Summary
- On March 12, 2025, Asif Ali, the Chief Financial Officer of Protagonist Therapeutics, executed transactions involving the company's stock.
- Ali exercised stock options to acquire 15,203 shares at $12.17 and 9,700 shares at $19.19.
- Simultaneously, Ali sold 24,903 shares at a weighted average price of $58.73, with individual sales ranging from $58.12 to $59.235.
- Following these transactions, Ali directly owns 62,821 shares of common stock.
- Ali also holds options to purchase 30,547 shares at $12.17 and 66,800 shares at $19.19.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard Form 4 filing detailing stock transactions. The transactions themselves don't necessarily indicate a positive or negative outlook.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 04/18/2022 | Date of grant for stock option vesting quarterly through April 18, 2026. |
| 01/16/2023 | Date of grant for stock option vesting monthly through January 15, 2033. |
| 04/18/2023 | First vesting date for stock option granted on April 18, 2022. |
| 03/12/2025 | Date of stock option exercise and stock sale transactions. |
| 03/14/2025 | Date of Form 4 signature. |
| 04/18/2026 | Final vesting date for stock option granted on April 18, 2022. |
| 01/15/2033 | Expiration date for stock option granted on January 16, 2023. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.